Printer Friendly

Articles from M2 Pharma (November 1, 2019)

1-10 out of 10 article(s)
Title Author Type Words
ACADIA Pharmaceuticals starts phase three LAVENDER placebo-controlled study to assess Trofinetide. Clinical report 259
Amgen, BeiGene sign strategic collaboration. 301
Beam Therapeutics partners with Prime Medicine for developing prime editing technology. 204
Invenra expands B-Body technology collaboration with Exelixis. 169
Meitheal Pharmaceuticals signs majority stake investment agreement with Nanjing King-Friend Biochemical Pharmaceutical Company. 138
Pandion Therapeutics signs license and collaboration contract with Astellas Pharma. 206
Pharma Logistics acquires pharmaceutical reverse distribution division of Stericycle Inc. 152
SignPath Pharma signs out-license agreement for CorreQT technology platform with Rain Therapeutics. 169
SP Industries acquires Irta Dosificacio I Technologia. 150
The European Medicines Agency validates Roche's Marketing Authorisation Application for Satralizumab. 199

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters